Trial Profile
A Randomized, Double-blind Placebo-controlled Phase III Trial of Coenzyme Q10 in Gulf War Illness
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Feb 2023
Price :
$35
*
At a glance
- Drugs Ubiquinol (Primary)
- Indications Persian-gulf-syndrome
- Focus Therapeutic Use
- 02 Feb 2021 Status changed from active, no longer recruiting to completed.
- 22 Apr 2020 Status changed from recruiting to active, no longer recruiting.
- 03 Mar 2020 Planned End Date changed from 30 Sep 2020 to 31 Dec 2020.